NGN Optiscan Fund III, L.P. is a private investment fund based in Stamford, Connecticut. According to its most recent Form D, filed Feb 3, 2020, it has sold $199,000 of interests to 4 investors since its first sale in Jan 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include NGN Capital LLC; NGN BioMed I GP, L.P.
- Total raised
- $199,000Cumulative sales reported on Form D
- Investors
- 4
- First sale
- Jan 29, 2020
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- NGN Capital LLC; NGN BioMed I GP, L.P
- Latest Form D
- Feb 3, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NGN Optiscan Fund III, L.P.
What is the minimum investment for NGN Optiscan Fund III, L.P.?
NGN Optiscan Fund III, L.P.'s latest Form D, filed Feb 3, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in NGN Optiscan Fund III, L.P.?
NGN Optiscan Fund III, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has NGN Optiscan Fund III, L.P. raised?
NGN Optiscan Fund III, L.P. reports $199,000 sold from 4 investors on its Form D filed Feb 3, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is NGN Optiscan Fund III, L.P. based?
NGN Optiscan Fund III, L.P. is based in Stamford, Connecticut.
When did NGN Optiscan Fund III, L.P. launch?
NGN Optiscan Fund III, L.P. reports its first sale in Jan 2020.
Size compared with every private investment fund
Raised more than 19% of the 306 private investment funds based in Connecticut, and more than 4% of all 10,377 that report sales.